Skip to main content

XBiotech Inc.

XBIT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001626878

No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding XBiotech Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of XBIT: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders39390
Shares2.45M3.48M+1.04M (+42.4%)
Value$8.61M$20.7M+$12.1M (+140.4%)

New holders (6)

Institutions that held XBiotech Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to XBIT in Q2 2023
InstitutionSharesValue% of portfolio
Empowered Funds, LLC49,776$295.7K0.01%
EA Series Trust49,776$295.7K0.01%
Jane Street Group, LLC13,207$78.5K0.00%
Virtu Financial LLC10,410$62.0K0.00%
Rhumbline Advisers753$4.47K0.00%
Group One Trading, L.P.166$9860.00%

Sold out (6)

Institutions that held XBiotech Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of XBIT in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Susquehanna International Group, LLP38,163$131.7K
Susquehanna Fundamental Investments, LLC20,863$72.0K
State of Wisconsin Investment Board19,700$68.0K
Tower Research Capital LLC (TRC)236$1.00K
Financial Connections Group, Inc.500$1.00K
TD Waterhouse Canada Inc.200$928